Efficacy and safety of pregabalin in refractory focal epilepsy with and without comorbid anxiety disorders — Results of an open-label, parallel group, investigator-initiated, proof-of-concept study

  • Christian Brandt, Martin Schoendienst, Monika Trentowska, Mario Schrecke, Nora Fueratsch, Karin Witte-Boelt, Bernd Pohlmann-Eden, Theodor W. May
  • Epilepsy & Behavior, November 2013, Elsevier
  • DOI: 10.1016/j.yebeh.2013.08.004

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1016/j.yebeh.2013.08.004

The following have contributed to this page: Dr Christian Brandt